Vincerx Pharma, Inc. (VINC) Ownership
VINC ownership summary
as of October 21, 2026- Institutions
- 5.3% of shares outstanding
- Insiders
- 4.07% of shares outstanding
- Shares outstanding
- 5.2M
- Float
- 4.7M shares available to trade
- Short interest
- 2.64% 137K shares short
- Days to cover
- 0.07 short interest up 99.4% vs prior month
- Institutions 5.25%
- Insiders 4.07%
- Other investors 90.67%
VINC top institutional holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Bank & Trust Co | 0.00% | — | — | −50 (−100.0%) | September 30, 2025 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 1, 0 holders added 0 shares and 1 cut 50.
VINC top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Diversified Equity Alpha Inst | <0.01% | 83 | $1 | — | June 30, 2026 |
| 2 | Guggenheim Active Allocation Fund | <0.01% | 8 | $0 | +4 (+100.0%) | May 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VINC insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-11 | Alexander A Seelenberger | Buy | $19.00 | 525 | $9,975 |
| 2023-08-09 | Ahmed Md Hamdy | Buy | $19.00 | 845 | $16,055 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VINC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VINC
Institutional investors own 5.3% of Vincerx Pharma's shares and insiders 4.07%. The largest holder is Bank & Trust Co with 0.00% of the shares (0), as of September 30, 2025. Among the top 1 institutions, 0 added shares and 1 reduced their stake in the latest filings. Short interest is 2.64% of the float, or 0.07 days of average trading volume. The share count rose 265.3% since 2019.
Related: VINC analyst forecast, VINC key metrics. See the VINC stock overview for the latest quote and news.
VINC ownership FAQ
Who owns the most Vincerx Pharma stock?
The largest shareholders of Vincerx Pharma are Bank & Trust Co (0.00%).
What percentage of Vincerx Pharma is owned by institutions?
Institutions hold 5.3% of Vincerx Pharma's shares outstanding; insiders hold 4.07%.
Which funds own Vincerx Pharma?
The largest fund holders of Vincerx Pharma are BlackRock Diversified Equity Alpha Inst (<0.01%), Guggenheim Active Allocation Fund (<0.01%).
What is Vincerx Pharma's short interest?
137K shares of Vincerx Pharma were sold short, 2.64% of the float; at the average daily volume it would take 0.07 days to cover.
Are insiders buying or selling Vincerx Pharma?
Of the latest 2 reported insider transactions in Vincerx Pharma (since August 9, 2023), 2 were purchases and 0 were sales.
How many shares of Vincerx Pharma are outstanding?
Vincerx Pharma has 5.2M shares outstanding, of which 4.7M are in the public float.